Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Baseline characteristics of the study samples.

More »

Table 1 Expand

Table 2.

Crude mortality incidence rate ratios for the dementia and non-dementia group.

More »

Table 2 Expand

Table 3.

Crude mortality incidence rate ratio among the vascular dementia and non-vascular dementia groups.

More »

Table 3 Expand

Fig 1.

Kaplan-Meier survival estimates.

The median survival times were 9.23 years for the non-dementia group, 5.50 years for vascular dementia, and 4.99 years for degenerative dementia.

More »

Fig 1 Expand

Fig 2.

Kaplan-Meier survival estimates.

The median survival times were 9.23 years for the non-dementia group, 3.01 years for degenerative dementia without medications, 8.11 years for degenerative dementia with anti-dementia medications, 6.00 years for degenerative dementia with nootropics, and 9.03 years for degenerative dementia with both nootropic and anti-dementia medications.

More »

Fig 2 Expand

Fig 3.

Kaplan-Meier survival estimates.

The median survival times were 9.23 years for the non-dementia group, 3.39 years for vascular dementia without medications, and 6.62 years for vascular dementia with nootropics.

More »

Fig 3 Expand

Table 4.

Hazard ratios in the vascular dementia and degenerative dementia groups.

More »

Table 4 Expand